Koyama Eriko, Sakai Norifumi, Ohori Yuji, Kitazawa Ken, Izawa Osamu, Kakegawa Kunio, Fujino Akiharu, Ui Michio
Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 14 Sunayama, Hasaki-machi, Ibaraki, 314-0255, Kashima-gun, Japan.
Food Chem Toxicol. 2003 Jun;41(6):875-83. doi: 10.1016/s0278-6915(03)00039-5.
Stevia mixture, sweeteners extracted from the leaves of Stevia rebaudiana Bertoni, consists mainly of the glycosides of the diterpene derivative steviol. The aims of this study were to investigate the absorption (in rats) and the hepatic metabolism (in rats and humans) of both stevia mixture and steviol. Absorption was investigated both in vivo and ex vivo. In ex vivo experiments using the rat everted sac method, no absorption of stevia mixture was observed, but significant absorption of steviol was noted (equivalent to approximately 70% of the absorption reference- salicylic acid- value). In the in vivo experiment, rats received a single oral administration of either steviol or stevia mixture; a peak steviol concentration in plasma was observed 15 min after its oral administration, demonstrating rapid absorption. However, after oral administration of stevia mixture, the steviol concentration in plasma increased steadily over 8 h, suggesting that stevia mixture components are first degraded and then absorbed as steviol in the rat intestine. Steviol metabolism in humans and rats was examined by incubating steviol with liver microsomes from the two species. Oxidative (monohydroxy and dihydroxy) metabolites of steviol were observed by LC-ESI/MS after incubation with both human and rat liver microsomes. The intrinsic clearance of steviol in human liver microsomes was 4-times lower than that found in rat liver microsomes. In conclusion, this study suggests that there are no major species differences in steviol hepatic metabolism between rats and humans. Absorption from the human intestine can be predicted to occur in an analogous manner to that from the rat intestine.
甜菊混合物是从甜叶菊(Stevia rebaudiana Bertoni)叶子中提取的甜味剂,主要由二萜衍生物甜菊醇的糖苷组成。本研究的目的是研究甜菊混合物和甜菊醇在大鼠体内的吸收情况以及在大鼠和人类体内的肝脏代谢情况。吸收情况通过体内和体外实验进行研究。在使用大鼠外翻肠囊法的体外实验中,未观察到甜菊混合物的吸收,但甜菊醇有显著吸收(相当于吸收参比物水杨酸吸收值的约70%)。在体内实验中,大鼠单次口服甜菊醇或甜菊混合物;口服甜菊醇后15分钟在血浆中观察到甜菊醇浓度峰值,表明吸收迅速。然而,口服甜菊混合物后,血浆中甜菊醇浓度在8小时内稳步上升,这表明甜菊混合物的成分首先被降解,然后在大鼠肠道中作为甜菊醇被吸收。通过将甜菊醇与人及大鼠的肝脏微粒体一起孵育来研究甜菊醇在人和大鼠体内的代谢。在与人和大鼠肝脏微粒体孵育后,通过液相色谱-电喷雾电离质谱法(LC-ESI/MS)观察到了甜菊醇的氧化(单羟基和二羟基)代谢产物。甜菊醇在人肝脏微粒体中的内在清除率比在大鼠肝脏微粒体中低4倍。总之,本研究表明大鼠和人类在甜菊醇肝脏代谢方面没有主要的种属差异。可以预测,人肠道的吸收方式与大鼠肠道类似。